Siemens Inofansparin Reagent Group - Taiwan Registration 3cf7c00c6fa4d6f2d759e3d2a3b81d23
Access comprehensive regulatory information for Siemens Inofansparin Reagent Group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 3cf7c00c6fa4d6f2d759e3d2a3b81d23 and manufactured by SIEMENS HEALTHCARE DIAGNOSTICS PRODUCTS GMBH. The authorized representative in Taiwan is SYSMEX TAIWAN CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product uses in vitro diagnostic automatic color detection method to quantitatively detect the activity of unfractionated heparin (UFH) and low molecular weight heparin (LMWH) in human plasma.
B Haematology, pathology and genetics; A Clinical chemistry and clinical toxicology
A.1150 calibration;; B.7525 Heparin analysis;; B.5425 Versatile system for in vitro agglutination studies
import
Dates and Status
Apr 30, 2019
Apr 30, 2029